Fetub is considered to be a novel secretory adipokine/hepatic factor that is regulated in human steatosis (significantly increased in hepatic steatosis) and mediates impaired insulin action and glucose intolerance (Meex et al., 2015; Kralisch et al., 2017). Here, INS is linked to fatty liver disease.